Munich, Germany

Hans-Juergen Woerle

USPTO Granted Patents = 15 


 

Average Co-Inventor Count = 5.0

ph-index = 8

Forward Citations = 192(Granted Patents)


Location History:

  • Grandvaux, CH (2019 - 2023)
  • Grandvaux VD, CH (2021 - 2023)
  • Munich, DE (2014 - 2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovations of Hans-Juergen Woerle

Introduction

Hans-Juergen Woerle is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of diabetes treatment, holding a total of 15 patents. His work focuses on developing therapies that address metabolic diseases, particularly diabetes, and its associated complications.

Latest Patents

Among his latest patents is a groundbreaking invention related to vasoprotective and cardioprotective antidiabetic therapy. This invention involves certain DPP-4 inhibitors that are effective in treating and preventing oxidative stress, vascular stress, and endothelial dysfunction. It also highlights the use of these inhibitors in both diabetic and non-diabetic patients, especially those at risk of cardiovascular and renal diseases. Another notable patent addresses treatment for diabetes in patients who experience insufficient glycemic control despite existing therapies. This invention emphasizes the suitability of specific DPP-4 inhibitors for managing metabolic diseases in such patients.

Career Highlights

Hans-Juergen Woerle is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company has been instrumental in advancing diabetes therapies and improving patient outcomes. His innovative approaches have garnered attention in the medical community and have the potential to change the landscape of diabetes treatment.

Collaborations

Some of his notable coworkers include Uli Christian Broedl and Maximilian Von Eynatten. Their collaborative efforts have contributed to the success of various projects and innovations within the company.

Conclusion

Hans-Juergen Woerle's contributions to diabetes treatment through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical therapies that can significantly improve the quality of life for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…